HomeInsightsStock Comparison

Mercury Laboratories Ltd vs Solara Active Pharma Sciences Ltd Stock Comparison

Mercury Laboratories Ltd vs Solara Active Pharma Sciences Ltd Stock Comparison

Last Updated on: Sep 13, 2025

Key Highlights

  • The Latest Trading Price of Mercury Laboratories Ltd is ₹ 857.5 as of 12 Sep 15:30.
  • The P/E Ratio of Mercury Laboratories Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Solara Active Pharma Sciences Ltd changed from 10.4 on March 2020 to 3943 on March 2025 . This represents a CAGR of 169.04% over 6 years.
  • The Market Cap of Mercury Laboratories Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Solara Active Pharma Sciences Ltd changed from ₹ 1190 crore on March 2020 to ₹ 2005 crore on March 2025 . This represents a CAGR of 9.08% over 6 years.
  • The revenue of Mercury Laboratories Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Solara Active Pharma Sciences Ltd for the Jun '25 is ₹ 320.13 crore as compare to the Mar '25 revenue of ₹ 278.96 crore. This represent the growth of 14.76%.
  • The ebitda of Mercury Laboratories Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Solara Active Pharma Sciences Ltd for the Jun '25 is ₹ 58 crore as compare to the Mar '25 ebitda of ₹ 51.32 crore. This represent the growth of 13.02%.
  • The net profit of Mercury Laboratories Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Solara Active Pharma Sciences Ltd changed from ₹ -19.11 crore to ₹ 10.52 crore over 9 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Mercury Laboratories Ltd changed from 7.43 % on March 2020 to 13.38 % on March 2025 . This represents a CAGR of 10.30% over 6 yearsThe Dividend Payout of Solara Active Pharma Sciences Ltd changed from 4.77 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Mercury Laboratories Ltd

  • Mercury Laboratories Limited, the registered partnership firm started its business activity in year 1962.
  • Subsequently, the Company converted into Private Limited Company & incorporated in February, 1982.
  • Later, it further converted into Limited Company in 1992 in Maharashtra.
  • The Company is engaged in the business of Pharmaceutical items, medicinal drugs and formulations.
  • It is a profit making and dividend paying public limited company.

About Solara Active Pharma Sciences Ltd

  • Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs).
  • The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets.
  • The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others.
  • It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches.

Mercury Laboratories Ltd News Hub

News

Mercury Laboratories to convene board meeting

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 13 Au...

Read more

06 Aug 2025 11:26

News

Board of Mercury Laboratories recommends final dividend

Mercury Laboratories announced that the Board of Directors of the Company at its meeting h...

Read more

14 May 2025 17:14

News

Mercury Laboratories schedules AGM

Mercury Laboratories announced that the 44th Annual General Meeting(AGM) of the company wi...

Read more

14 May 2025 17:14

News

Mercury Laboratories to announce Quarterly Result

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 14 Ma...

Read more

08 May 2025 15:24

News

Mercury Laboratories to table results

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 12 Fe...

Read more

07 Feb 2025 10:22

News

Mercury Laboratories schedules board meeting

Mercury Laboratories will hold a meeting of the Board of Directors of the Company on 14 No...

Read more

07 Nov 2024 16:57

Solara Active Pharma Sciences Ltd News Hub

News

Solara Active Pharma Sciences to conduct AGM

Solara Active Pharma Sciences announced that the Annual General Meeting(AGM) of the compan...

Read more

04 Sep 2025 15:30

News

Solara Active Pharma Sciences to announce Quarterly Result

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

19 Jul 2025 10:30

News

Solara Active Pharma's Ambernath facility clears USFDA inspection

The Agency with their designated investigator inspected the facility from 5th to 9th May 2...

Read more

12 May 2025 08:36

News

Solara Active Pharma Sciences to conduct board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

07 May 2025 17:24

News

Solara Active Pharma Sciences to convene board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

27 Mar 2025 10:23

News

Solara Active Pharma Sciences to hold board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

22 Mar 2025 10:11

SWOT Analysis Of Mercury Laboratories Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Solara Active Pharma Sciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Mercury Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Solara Active Pharma Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Mercury Laboratories Ltd and Solara Active Pharma Sciences Ltd

Which company has a larger market capitalization, Mercury Laboratories Ltd or Solara Active Pharma Sciences Ltd?

Market cap of Mercury Laboratories Ltd is 102 Cr while Market cap of Solara Active Pharma Sciences Ltd is 2,996 Cr

What are the key factors driving the stock performance of Mercury Laboratories Ltd and Solara Active Pharma Sciences Ltd?

The stock performance of Mercury Laboratories Ltd and Solara Active Pharma Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mercury Laboratories Ltd and Solara Active Pharma Sciences Ltd?

As of September 13, 2025, the Mercury Laboratories Ltd stock price is INR ₹857.5. On the other hand, Solara Active Pharma Sciences Ltd stock price is INR ₹676.15.

How do dividend payouts of Mercury Laboratories Ltd and Solara Active Pharma Sciences Ltd compare?

To compare the dividend payouts of Mercury Laboratories Ltd and Solara Active Pharma Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions